An antigen-encapsulating nanoparticle platform for T(H)1/17 immune tolerance therapy

Tolerogenic nanoparticles (NPs) are rapidly being developed as specific immunotherapies to treat autoimmune disease. However, many NP-based therapies conjugate antigen (Ag) directly to the NP posing safety concerns due to antibody binding or require the co-delivery of immunosuppressants to induce to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nanomedicine
Egile Nagusiak: McCarthy, Derrick P., Yap, Jonathan Woon-Teck, Harp, Christopher T., Song, W. Kelsey, Chen, Jeane, Pearson, Ryan M., Miller, Stephen D., Shea, Lonnie D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237397/
https://ncbi.nlm.nih.gov/pubmed/27720992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.09.007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak